Le Lézard

Communiqués de presse par sujet : Santé

1 2 3 4 5 6 7 8 9 10

Aujourd'hui

09:03
Altasciences is pleased to have partnered with Xeris Pharmaceuticals, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables, on a randomized,...

09:03
Altasciences est heureuse d'avoir collaboré avec Xeris Pharmaceuticals, une entreprise pharmaceutique spécialisée qui utilise ses nouvelles plateformes technologiques de formulation pour élaborer et commercialiser des produits injectables de liquide...


12 juillet 2018

11:03
Dr. Howard Gimbel, one of the world's leading ophthalmic surgeons, and the Gordie Howe of the ophthalmic community, will soon transition away from surgical practice. Due to a cancerous tumour that cannot be treated with radiation or chemotherapy,...


11 juillet 2018

11:33
Today, TELUS and Doctors of the World Canada announced the launch of the innovative TELUS Health for Goodtm program in Victoria. Doctors of the World, with community partners and voluntary health practitioners, will leverage the Mobile Health Clinic,...

07:33
Akcea Therapeutics, Inc. , an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. , announced today that TEGSEDITM (inotersen) has received marketing authorization approval from the European Commission (EC) for the treatment of...


10 juillet 2018

11:33
iRhythm Technologies, Inc. , a leading digital health care solutions company focused on the advancement of cardiac care, today announced that results of the mHealth Screening to Prevent Strokes (mSToPS) study, which showed increased detection of...

11:03
Johanne Dodon, an evidence-based energy healer, announces today scientific research results on the significant impact of a biofield energy treated nutraceutical to improve skin health parameters including anti-wrinkling, skin hydration, elasticity,...


9 juillet 2018

16:18
Translational Research In Oncology (TRIO) today announced a collaboration with Novartis on its upcoming phase III clinical trial of ribociclib with endocrine therapy in the adjuvant treatment of HR-positive, HER2-negative early breast cancer (EBC)....


6 juillet 2018

08:33
MPX Bioceutical Corporation ("MPX" or the "Company") released the following statement in response to the decision by the Arizona Court of Appeals rendered on June 26, 2018 affirming the Yavapai County Superior Court decision convicting Rodney...


5 juillet 2018

19:33
The final analysis at 18 months of the 856 patient Phase II clinical study in early Alzheimer's disease demonstrated statistically significant slowing in clinical decline and reduction of amyloid beta accumulated in the brainFirst late-stage study...


4 juillet 2018

10:33
GOeVisit SmartExam (SmartExam), a service pioneered by MyCare MedTech Inc., is taking virtual health care to the next level by providing Canadians with a cutting-edge platform for receiving medical treatment. Its brand-new software application...

07:33
Theratechnologies Inc. (Theratechnologies) a annoncé aujourd'hui qu'elle a déposé un supplemental new drug application (sNDA) auprès de la Food and Drug Administration (FDA) pour une formulation en fiole unique d'EGRIFTAMD.  La soumission s'appuie...

07:33
Theratechnologies Inc. (Theratechnologies) today announced that it has filed a supplemental new drug application (sNDA) with the Food and Drug Administration (FDA) for a single-vial formulation of EGRIFTA®.  The filing is based on bioequivalence...


3 juillet 2018

13:03
Twenty-four hours after being sworn in as Ontario's new Premier, Doug Ford's government issued a press release on the Canada Day weekend revealing a plan to cut health care coverage. Details are scant. It appears that the plan is to roll back OHIP+...

08:33
Body and Mind Inc. (US OTC:BMMJ), (the "Company", "Body and Mind" or "BAM") announces approval of the final building inspection for the Phase II expansion from the Clark County Department of Building and Fire Prevention. The company initiated the...


29 juin 2018

11:33
Isodiol International Inc. (the "Company" or "Isodiol"), a global CBD innovator and market leader, announces plans to pursue a...

08:03
Extendicare Inc. ("Extendicare" or the "Company") announced today that it plans to release its financial results for the second quarter of 2018, after market close on Thursday, August 9, 2018. A conference call hosted by Tim Lukenda, President and...


28 juin 2018

09:03
Lyfebulb LLC and UnitedHealth Group have selected 11 Patient Entrepreneur finalists who will compete in the "Empowering Patients: An Innovation Challenge" to earn the Lyfebulb and UnitedHealth Group Innovation Award. After a thorough...


27 juin 2018

16:33
CohBar, Inc. , an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that it has completed sales of approximately 2,187,000 shares of its common stock at an average price...

10:03
Isodiol International Inc. (the "Company" or "Isodiol"), a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an...

07:03
Revive Therapeutics Ltd. ("Revive" or the "Company"), a company focused on the research, development and commercialization of novel cannabinoid-based therapies, today announced that the U.S. Food and Drug Administration ("FDA") has granted orphan...

06:33
Avivagen Inc. ("Avivagen" or the "Corporation"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health...

05:33
GB Sciences, Inc. has filed a new provisional patent application on the use of cannabis-based therapies for the manipulation of cannabis-sensitive ion channels in sensory neurons that contribute to chronic inflammatory pain conditions, peripheral...


25 juin 2018

12:33
CohBar, Inc. , an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced the presentation of preclinical data on CB4211, its lead MBT candidate under development as...

07:03
Octapharma announced today the launch of the Canadian PREVAIL (Immune Tolerance Induction in Hemophilia A Patients using Wilate®) study for patients with Hemophilia A.  The PREVAIL study will enroll hemophilia A patients who have recently developed...

07:03
Octapharma a annoncé aujourd'hui le lancement de l'étude canadienne PREVAIL, une étude sur l'utilisation de Wilate® pour favoriser l'induction de la tolérance immunitaire (ITI) chez des patients atteints d'hémophilie A. L'étude PREVAIL recrutera des...


21 juin 2018

17:03
The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") is pleased to announce that it has decided to add a 287,245 sq ft purpose-built facility on its Valleyfield property capable of producing 40,000 kgs of premium organic cannabis....

06:03
Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate (STS)), announced today a publication in the June 21, 2018 issue of the New England Journal of...


19 juin 2018

09:33
Sandoz Canada and Tilray finalize alliance to provide Canadians with greater access to high-quality, non-combustible medical cannabis options; Eight co-branded oil and capsule medical cannabis products are available to the 270,000 Canadian patients...

08:03
(June 19, 2018)? Sun-Rype Products Ltd. ("SunRype" or the "Company"), a manufacturer and marketer of healthy food and beverage products, today announced that they have partnered with Mamas for Mamas charitable organization. Over the next 12 months,...

08:03
With the imminent legalization of marijuana, a new public opinion poll shows that nearly 9 out of 10 of Canadians support applying the current branding and packaging regulations to both tobacco and marijuana cigarettes. In light of these findings,...

07:03
Zomedica Pharmaceuticals Corp. ("Zomedica" or the "Company"), a veterinary diagnostic and pharmaceutical company, today provided a product development update. Diagnostic Update ZM-017: Circulating tumor cell assay platform for dogs As previously...

07:03
Sandoz Canada and Tilray finalize alliance to provide Canadians with greater access to high-quality, non-combustible medical cannabis options; Eight co-branded oil and capsule medical cannabis products are available to the 270,000 Canadian patients...


18 juin 2018

07:33
BELGRAVIA CAPITAL INTERNATIONAL INC. ("Belgravia" or the "Company") today announced that its subsidiary, Belgravia Dermatology Inc. ("Belgravia Dermatology") has completed the selection of initial drug targets and biological markers for its...

07:33
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, updated today the expected timing for the Company's submission of a request for U.S. Food and Drug Administration ("FDA", "Agency")...


14 juin 2018

19:33
1600978 Ontario Inc. (which operates as Natural MedCo) ("NMC") and Carlaw Capital V Corp. ("Carlaw") (NEX:CVC.H), are pleased to provide an update to...


13 juin 2018

08:03
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the Community-Based Healthcare market, is pleased to announce that six new primary...


12 juin 2018

17:03
JDRF Canada applauds the British Columbia government's announcement today extending the province's current insulin pump program to all ages.  BC now joins Ontario, Alberta and the Territories in providing publicly funded insulin pumps and supplies...

14:03
The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that Snapchat now requires United States and Canadian pharmacies that wish to advertise on its platform to be verified by NABP. Snapchat's new advertising policy, found in...

13:03
Innovative OncoSolutions Inc. (IOS) announced today a fully compliant NAPRA quality management system for the Canadian pharmacy compounding market. "CompoundingQMS is the first quality management system that includes all the NAPRA/797/ 800 Model...


11 juin 2018

19:03
10330698 Canada Ltd. (dba Compass Cannabis Clinics, "Compass") is pleased to announce that it has entered into a letter of intent with Dr. Teresa Towpik which will signal the launch of its operations in Australia under a joint venture entity to be...

15:33
The Canada Green Building Council (CaGBC) awarded PCL Constructors Canada Inc. (Toronto) and its partners with its 2018 Excellence in Green Building: New Construction Institutional Award for Humber River Hospital (HRH), in recognition of the team's...

09:33
The Tenth World Salt Symposium will be held June 19-21, 2018 in Park City, Utah, and will feature nearly 100 presentations from around the globe covering all topics related to salt. Starting in the 1960's, people from around the world have gathered...

07:03
Canadian Blood Services is getting ready to support patients this summer and is inviting Canadians to participate in the international Missing Type campaign from June 11 to 17. The Missing Type campaign is taking place during National Blood Donor...

07:03
Pour pouvoir répondre aux besoins des patients cet été, la Société canadienne du sang invite la population à participer à la campagne internationale Groupe manquant qui a lieu pendant la Semaine nationale du don de sang, du 11 au 17 juin, dont c'est...


7 juin 2018

07:03
True Leaf Medicine International Ltd. ("True Leaf") , a plant-focused wellness brand for people and their pets, is pleased to report the construction of its cannabis cultivation facility, True Leaf Campus, being built in Lumby, British Columbia, is...

07:03
Sandoz Canada est la première entreprise au Canada à offrir le lévétiracétam dans une concentration de 1 000 mg, ce qui permet aux patients de réduire le nombre de comprimés à prendre quotidiennement.PrSandoz Levetiracetam® est indiqué comme...

07:03
Sandoz Canada is the first company in Canada to offer levetiracetam in the higher concentration 1000 mg, enabling patients to reduce the number of tablets they need to take daily.PrSandoz Levetiracetam® is indicated as adjunctive therapy in the...


6 juin 2018

12:03
Sheila Benson, an evidence-based healer, today released research results from preclinical trials on the beneficial impact of biofield energy healing treated Vitamin D3 on the strength and health of bones.   The preclinical research shows: Over...

07:03
InMode Aesthetic Solutions, the leader in cutting edge aesthetic medicine and technology solutions introduces EmbraceRF, a new facial contouring technique that address a treatment gap in current modalities offered to patients. EmbraceRF targets the...

1 2 3 4 5 6 7 8 9 10